Simcere Pharmaceutical Group Limited
SMHGF
$0.6697
-$0.0641-8.74%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -152.38M | -21.67M | 112.69M | 281.73M | 452.75M |
| Total Depreciation and Amortization | 40.74M | 40.89M | 41.20M | 41.12M | 41.46M |
| Total Amortization of Deferred Charges | 3.60M | 3.07M | 2.53M | 2.12M | 1.73M |
| Total Other Non-Cash Items | 390.82M | 195.09M | -5.11M | -213.88M | -423.24M |
| Change in Net Operating Assets | -130.92M | -130.92M | -130.92M | -59.75M | 11.42M |
| Cash from Operations | 151.87M | 86.46M | 20.40M | 51.34M | 84.12M |
| Capital Expenditure | -66.82M | -66.82M | -66.82M | -57.48M | -49.16M |
| Sale of Property, Plant, and Equipment | 16.36M | 16.36M | 16.36M | 8.19M | 39.10K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 6.91M | 74.24M | 143.19M | 139.73M | 136.28M |
| Other Investing Activities | -48.76M | 8.15M | 66.01M | 56.33M | 46.43M |
| Cash from Investing | -92.30M | 31.94M | 158.74M | 146.77M | 133.59M |
| Total Debt Issued | 1.59B | 1.40B | 1.22B | 1.10B | 986.93M |
| Total Debt Repaid | -1.58B | -1.47B | -1.37B | -1.41B | -1.46B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -641.78M | -465.43M | -289.07M | -169.05M | -49.03M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -57.97M | -57.97M | -57.97M | -56.47M | -56.12M |
| Other Financing Activities | 925.87M | 445.20M | -35.47M | -35.22M | -34.98M |
| Cash from Financing | -17.02M | -71.37M | -126.72M | -130.68M | -135.96M |
| Foreign Exchange rate Adjustments | 336.70K | 509.00K | 686.20K | 1.50M | 2.34M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 42.89M | 47.54M | 53.11M | 68.93M | 84.09M |